The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden
The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for de...
Ausführliche Beschreibung
Autor*in: |
Lundin, Andreas [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
6 |
---|
Übergeordnetes Werk: |
Enthalten in: Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis - Heidari, Somaye-Sadat ELSEVIER, 2021, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:183 ; year:2015 ; day:1 ; month:09 ; pages:247-252 ; extent:6 |
Links: |
---|
DOI / URN: |
10.1016/j.jad.2015.05.024 |
---|
Katalog-ID: |
ELV012818100 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV012818100 | ||
003 | DE-627 | ||
005 | 20230623102019.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jad.2015.05.024 |2 doi | |
028 | 5 | 2 | |a GBVA2015004000003.pica |
035 | |a (DE-627)ELV012818100 | ||
035 | |a (ELSEVIER)S0165-0327(15)00324-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 570 |a 540 |q VZ |
100 | 1 | |a Lundin, Andreas |e verfasserin |4 aut | |
245 | 1 | 4 | |a The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
264 | 1 | |c 2015 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. | ||
650 | 7 | |a HSCL |2 Elsevier | |
650 | 7 | |a Sensitivity and specificity |2 Elsevier | |
650 | 7 | |a Depression |2 Elsevier | |
650 | 7 | |a Anxiety |2 Elsevier | |
650 | 7 | |a SCL |2 Elsevier | |
700 | 1 | |a Hallgren, Mats |4 oth | |
700 | 1 | |a Forsell, Yvonne |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Heidari, Somaye-Sadat ELSEVIER |t Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV000041335 |
773 | 1 | 8 | |g volume:183 |g year:2015 |g day:1 |g month:09 |g pages:247-252 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jad.2015.05.024 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 183 |j 2015 |b 1 |c 0901 |h 247-252 |g 6 | ||
953 | |2 045F |a 610 |
author_variant |
a l al |
---|---|
matchkey_str |
lundinandreashallgrenmatsforsellyvonne:2015----:hvldtoteypocekitersinnaxeyusaeaeea |
hierarchy_sort_str |
2015 |
publishDate |
2015 |
allfields |
10.1016/j.jad.2015.05.024 doi GBVA2015004000003.pica (DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Lundin, Andreas verfasserin aut The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier Hallgren, Mats oth Forsell, Yvonne oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 https://doi.org/10.1016/j.jad.2015.05.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 183 2015 1 0901 247-252 6 045F 610 |
spelling |
10.1016/j.jad.2015.05.024 doi GBVA2015004000003.pica (DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Lundin, Andreas verfasserin aut The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier Hallgren, Mats oth Forsell, Yvonne oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 https://doi.org/10.1016/j.jad.2015.05.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 183 2015 1 0901 247-252 6 045F 610 |
allfields_unstemmed |
10.1016/j.jad.2015.05.024 doi GBVA2015004000003.pica (DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Lundin, Andreas verfasserin aut The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier Hallgren, Mats oth Forsell, Yvonne oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 https://doi.org/10.1016/j.jad.2015.05.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 183 2015 1 0901 247-252 6 045F 610 |
allfieldsGer |
10.1016/j.jad.2015.05.024 doi GBVA2015004000003.pica (DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Lundin, Andreas verfasserin aut The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier Hallgren, Mats oth Forsell, Yvonne oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 https://doi.org/10.1016/j.jad.2015.05.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 183 2015 1 0901 247-252 6 045F 610 |
allfieldsSound |
10.1016/j.jad.2015.05.024 doi GBVA2015004000003.pica (DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ Lundin, Andreas verfasserin aut The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier Hallgren, Mats oth Forsell, Yvonne oth Enthalten in Elsevier Science Heidari, Somaye-Sadat ELSEVIER Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis 2021 Amsterdam [u.a.] (DE-627)ELV000041335 volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 https://doi.org/10.1016/j.jad.2015.05.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 183 2015 1 0901 247-252 6 045F 610 |
language |
English |
source |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 |
sourceStr |
Enthalten in Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis Amsterdam [u.a.] volume:183 year:2015 day:1 month:09 pages:247-252 extent:6 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
HSCL Sensitivity and specificity Depression Anxiety SCL |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
authorswithroles_txt_mv |
Lundin, Andreas @@aut@@ Hallgren, Mats @@oth@@ Forsell, Yvonne @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV000041335 |
dewey-sort |
3610 |
id |
ELV012818100 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012818100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102019.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.05.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012818100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)00324-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lundin, Andreas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sensitivity and specificity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anxiety</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hallgren, Mats</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forsell, Yvonne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:183</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:247-252</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.05.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">183</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">247-252</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Lundin, Andreas |
spellingShingle |
Lundin, Andreas ddc 610 ddc 570 Elsevier HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
authorStr |
Lundin, Andreas |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000041335 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 570 540 VZ The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL Elsevier |
topic |
ddc 610 ddc 570 Elsevier HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL |
topic_unstemmed |
ddc 610 ddc 570 Elsevier HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL |
topic_browse |
ddc 610 ddc 570 Elsevier HSCL Elsevier Sensitivity and specificity Elsevier Depression Elsevier Anxiety Elsevier SCL |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m h mh y f yf |
hierarchy_parent_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
hierarchy_parent_id |
ELV000041335 |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
hierarchy_top_title |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000041335 |
title |
The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
ctrlnum |
(DE-627)ELV012818100 (ELSEVIER)S0165-0327(15)00324-9 |
title_full |
The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
author_sort |
Lundin, Andreas |
journal |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
journalStr |
Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
247 |
author_browse |
Lundin, Andreas |
container_volume |
183 |
physical |
6 |
class |
610 610 DE-600 570 540 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Lundin, Andreas |
doi_str_mv |
10.1016/j.jad.2015.05.024 |
dewey-full |
610 570 540 |
title_sort |
validity of the symptom checklist depression and anxiety subscales: a general population study in sweden |
title_auth |
The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
abstract |
The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. |
abstractGer |
The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. |
abstract_unstemmed |
The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden |
url |
https://doi.org/10.1016/j.jad.2015.05.024 |
remote_bool |
true |
author2 |
Hallgren, Mats Forsell, Yvonne |
author2Str |
Hallgren, Mats Forsell, Yvonne |
ppnlink |
ELV000041335 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth |
doi_str |
10.1016/j.jad.2015.05.024 |
up_date |
2024-07-06T17:15:57.952Z |
_version_ |
1803850778363822080 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012818100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102019.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jad.2015.05.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012818100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0327(15)00324-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lundin, Andreas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The validity of the symptom checklist depression and anxiety subscales: A general population study in Sweden</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The Symptom Checklist (SCL) is used as a screening tool in patient settings, but is also used as a diagnostic proxy for depression and anxiety in public health surveys. However, there are few validation studies based on general population samples. This study aims to validate the SCL subscales for depression and anxiety in a general population sample in Stockholm, Sweden.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sensitivity and specificity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anxiety</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hallgren, Mats</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forsell, Yvonne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Heidari, Somaye-Sadat ELSEVIER</subfield><subfield code="t">Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000041335</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:183</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:247-252</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jad.2015.05.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">183</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">0901</subfield><subfield code="h">247-252</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.402667 |